GlassScriptPhysician profile
Jeffrey D Bunn
NPI 1760432868
$1,704.11
in general payments reported to CMS, 2019-2025
9 companies · $168 in 2025
The $168 reported for 2025 was less than what a typical Plastic Surgery Within The Head & Neck provider received nationally (typical 2025 total: $238).
See the full distribution for Plastic Surgery within the Head & Neck
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17.64 · 2022: $159 · 2023: $1,164 · 2024: $196 · 2025: $168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $989 · Food and Beverage: $539.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $989.18 |
| Food and Beverage | $538.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,147.69 | 2022-2023 | Inspire |
| Stryker Corporation | $167.63 | 2025 | Vsp System, Vsp Cranial, Adherus Autospray Et Dural Sealant, Na |
| Astrazeneca Pharmaceuticals LP | $124.99 | 2023 | Tezspire |
| Polynovo North America LLC | $97.77 | 2024 | Novosorb Btm |
| Ascendis Pharma Endocrinology INC | $78.48 | 2024 | |
| Exelixis INC. | $31.80 | 2023 | Cabometyx |
| Glaxosmithkline, LLC. | $20.19 | 2024 | Nucala |
| Depuy Synthes Sales INC. | $17.92 | 2023 | Matrixmandible |
| Genzyme Corporation | $17.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Bunn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.